{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:38:16Z","timestamp":1794137896134,"version":"4.8.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.breast.2025.103881","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T19:08:08Z","timestamp":1737400088000},"page":"103881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy"],"prefix":"10.1016","volume":"80","author":[{"given":"Meritxell","family":"Arenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"B\u00f6l\u00fckba\u015f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth J.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Offersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Kouloulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurdes","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Marazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Trovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Kaidar-Person","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icro","family":"Meattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Borghesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ciabattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Krengli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Krug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Masiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Montero","family":"Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pedretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Perrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Ratosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine","family":"Tramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2025.103881_bib1","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199511303332203","article-title":"Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer","volume":"333","author":"Fisher","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2025.103881_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0167-8140(89)90165-5","article-title":"Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer","volume":"14","author":"Sarrazin","year":"1989","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1470-2045(12)70042-6","article-title":"Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial","volume":"13","author":"Liti\u00e8re","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/0959-8049(95)00271-J","article-title":"Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients","volume":"31a","author":"Veronesi","year":"1995","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"key":"10.1016\/j.breast.2025.103881_bib5","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib6","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.1997.15.3.963","article-title":"Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France","volume":"15","author":"Romestaing","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.radonc.2018.06.020","article-title":"Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: results of the Young boost trial","volume":"128","author":"Brouwers","year":"2018","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.breast.2025.103881_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib10","article-title":"Young boost randomized phase III trial of high vs low boost radiation in young breast cancer patients: 10-year results","author":"Bosma","year":"2024","journal-title":"EBCC Milan, Italy European Journal of Cancer"},{"key":"10.1016\/j.breast.2025.103881_bib11","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/S0140-6736(23)00619-0","article-title":"Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial","volume":"401","author":"Coles","year":"2023","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.breast.2025.103881_bib12","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.20.01363","article-title":"Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase III trial: the DBCG HYPO trial","volume":"38","author":"Offersen","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib13","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib14","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.breast.2025.103881_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clon.2018.11.033","article-title":"Variation in the use of boost irradiation in breast-conserving therapy in The Netherlands: the effect of a national guideline and cofounding factors","volume":"31","author":"Schreuder","year":"2019","journal-title":"Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-016-3998-2","article-title":"The 2016 Assisi Think Tank Meeting on breast cancer: white paper","volume":"160","author":"Aristei","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.103881_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102967","article-title":"The 2018 assisi think tank meeting on breast cancer: international expert panel white paper","volume":"151","author":"Arenas","year":"2020","journal-title":"Crit Rev Oncol-Hematol"},{"key":"10.1016\/j.breast.2025.103881_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103774","article-title":"Ways to improve breast cancer patients' management and clinical outcome: the 2020 Assisi Think Tank Meeting","volume":"177","author":"Aristei","year":"2022","journal-title":"Crit Rev Oncol-Hematol"},{"key":"10.1016\/j.breast.2025.103881_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104035","article-title":"The 2022 Assisi Think Tank Meeting: white paper on optimising radiation therapy for breast cancer","volume":"187","author":"Aristei","year":"2023","journal-title":"Crit Rev Oncol-Hematol"},{"key":"10.1016\/j.breast.2025.103881_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijrobp.2007.06.035","article-title":"Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer","volume":"70","author":"Wahl","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2025.103881_bib21","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2005.02.8738","article-title":"Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies","volume":"24","author":"Nielsen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib22","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S0959-8049(02)00219-8","article-title":"Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women","volume":"38","author":"Fredriksson","year":"2002","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"key":"10.1016\/j.breast.2025.103881_bib23","first-page":"250","article-title":"Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy","volume":"211","author":"Veronesi","year":"1990","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2025.103881_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0360-3016(98)00365-4","article-title":"Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer","volume":"43","author":"Touboul","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2025.103881_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0360-3016(90)90271-K","article-title":"The prognostic significance of late local recurrence after breast-conserving therapy","volume":"18","author":"Kurtz","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2025.103881_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0360-3016(94)90513-4","article-title":"Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group","volume":"30","author":"Whelan","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2025.103881_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0360-3016(93)90382-6","article-title":"Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting","volume":"27","author":"Haffty","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2025.103881_bib28","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.22.00451","article-title":"Partial breast irradiation versus whole breast irradiation for early breast cancer patients in a randomized phase III trial: the Danish breast cancer group partial breast irradiation trial","volume":"40","author":"Offersen","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0360-3016(00)01378-X","article-title":"True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management","volume":"48","author":"Smith","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2025.103881_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00066-002-1053-1","article-title":"Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial","volume":"178","author":"Polgar","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.breast.2025.103881_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10549-013-2508-z","article-title":"The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial","volume":"139","author":"Hau","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.103881_bib32","first-page":"286","article-title":"Boosting conservative treatment: 6 year results of randomized trial","volume":"50","author":"Teissier","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.103881_bib33","article-title":"A comparison between sequential conventional and hypofractionated boost following whole-breast radiotherapy: a propensity score-matched analysis","volume":"15","author":"Rajan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.breast.2025.103881_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","article-title":"HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results - interim analysis","volume":"174","author":"Chakraborty","year":"2022","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2008.07.011","article-title":"Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial","volume":"90","author":"Poortmans","year":"2009","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib36","article-title":"Tumour bed boost radiotherapy for women after breast-conserving surgery","volume":"11","author":"Kindts","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.breast.2025.103881_bib37","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaoncol.2016.6948","article-title":"Association of radiotherapy boost for ductal carcinoma in situ with local control after whole-breast radiotherapy","volume":"3","author":"Moran","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib38","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJMoa010874","article-title":"Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation","volume":"345","author":"Bartelink","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2025.103881_bib39","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1200\/JCO.2008.21.7075","article-title":"Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel","volume":"27","author":"Millar","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib40","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3332\/ecancer.2021.1194","article-title":"Post-lumpectomy radiation therapy boost in breast cancer patients: evidence revisited","volume":"15","author":"Kayali","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.breast.2025.103881_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamaoncol.2016.3031","article-title":"Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC boost vs No boost trial: a randomized clinical trial","volume":"3","author":"Vrieling","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10549-011-1891-6","article-title":"Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype","volume":"133","author":"Lowery","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2025.103881_bib43","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2020.06.078","article-title":"De-intensifying radiation therapy in HER-2 positive breast cancer: to boost or not to boost?","volume":"108","author":"Abi Jaoude","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2025.103881_bib44","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004230","article-title":"Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy","volume":"95","author":"Cao","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.breast.2025.103881_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","article-title":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials","volume":"19","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib46","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(20)30580-5","article-title":"Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox","volume":"22","author":"Dubsky","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.radonc.2013.10.033","article-title":"Target volume delineation in external beam partial breast irradiation: less inter-observer variation with preoperative- compared to postoperative delineation","volume":"110","author":"van der Leij","year":"2014","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1515\/raon-2017-0014","article-title":"MRI reduces variation of contouring for boost clinical target volume in breast cancer patients without surgical clips in the tumour bed","volume":"51","author":"Al-Hammadi","year":"2017","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib49","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clbc.2020.06.005","article-title":"Hypofractionated whole breast irradiation and simultaneous integrated boost in large-breasted patients: long-term toxicity and cosmesis","volume":"20","author":"De Rose","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2025.103881_bib50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.radonc.2011.12.021","article-title":"Reducing interobserver variation of boost-CTV delineation in breast conserving radiation therapy using a pre-operative CT and delineation guidelines","volume":"103","author":"Boersma","year":"2012","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","article-title":"ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer","volume":"114","author":"Offersen","year":"2015","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2012.03.015","article-title":"How does imaging frequency and soft tissue motion affect the PTV margin size in partial breast and boost radiotherapy?","volume":"103","author":"Harris","year":"2012","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ejso.2008.09.005","article-title":"Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT Trial Management Group","volume":"35","author":"Coles","year":"2009","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib54","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ejso.2015.07.011","article-title":"The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy","volume":"41","author":"Lansu","year":"2015","journal-title":"Eur J Surg Oncol : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103996","article-title":"Use of tumour bed boost radiotherapy in volume replacement oncoplastic breast surgery: a systematic review","volume":"186","author":"Garreffa","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.breast.2025.103881_bib56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2004.03.007","article-title":"The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial","volume":"72","author":"Poortmans","year":"2004","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2013.08.037","article-title":"Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence","volume":"108","author":"Bantema-Joppe","year":"2013","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib58","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3389\/fonc.2020.00628","article-title":"Precision medicine and the role of biomarkers of radiotherapy response in breast cancer","volume":"10","author":"Meehan","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16101942","article-title":"Clinical biomarkers of tumour radiosensitivity and predicting benefit from radiotherapy: a systematic review","volume":"16","author":"Bleaney","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.breast.2025.103881_bib60","article-title":"Validation of a breast cancer assay for radiotherapy omission: an individual participant data meta-analysis","author":"Karlsson","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2025.103881_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03008916221088885","article-title":"AIRO breast cancer group best clinical practice 2022 update","volume":"108","author":"Ciabattoni","year":"2022","journal-title":"Tumori"},{"key":"10.1016\/j.breast.2025.103881_bib62","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2025.103881_bib63","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1200\/JCO.2014.55.1572","article-title":"Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology\/American Society for Radiation Oncology consensus guideline","volume":"32","author":"Buchholz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030751","article-title":"CANTO-RT: one of the largest prospective multicenter cohort of early breast cancer patients treated with radiotherapy including full DICOM RT data","volume":"15","author":"Sarrade","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.breast.2025.103881_bib65","doi-asserted-by":"crossref","first-page":"S728","DOI":"10.1016\/S0167-8140(24)03367-X","article-title":"Dbcg IMN2: internal mammary node irradiation in 4541 high-risk breast cancer patients treated 2007-2014. ESTRO. Glasgow","author":"Nielsen","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109698","article-title":"Mapping the location of local and regional recurrences according to breast cancer surgery and radiation therapy: results from EORTC 22922\/10925","volume":"185","author":"Kaidar-Person","year":"2023","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clon.2024.08.010","article-title":"Radiotherapy trends and variations in invasive non-metastatic breast cancer treatment in The Netherlands: a nationwide overview from 2008 to 2019","volume":"36","author":"Evers","year":"2024","journal-title":"Clin Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110060","article-title":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)","volume":"195","author":"Kaidar-Person","year":"2024","journal-title":"Radiother Oncol : journal of the European Society for Therapeutic Radiology and Oncology"},{"key":"10.1016\/j.breast.2025.103881_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-084488","article-title":"Protocol for the development of a core outcome set and reporting guidelines for locoregional treatment in neoadjuvant systemic breast cancer treatment trials: the PRECEDENT project","volume":"14","author":"Potter","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.breast.2025.103881_bib70","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2019-000562","article-title":"UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)","volume":"4","author":"Vaz-Luis","year":"2019","journal-title":"ESMO Open"},{"key":"10.1016\/j.breast.2025.103881_bib71","series-title":"DBCG phase III randomized trial of hypo- vs standard fractionated RT in 2879 pN+ breast cancer pts","first-page":"S76","author":"Offersen","year":"2022"},{"key":"10.1016\/j.breast.2025.103881_bib72","doi-asserted-by":"crossref","first-page":"S625","DOI":"10.1016\/S0167-8140(23)08699-1","article-title":"HypoG01:UNICANCER phase 3 trial of locoregional hypo vs normo fractionated RT in early breast cancer","author":"Rivera","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.breast.2025.103881_bib73","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977625000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T19:41:43Z","timestamp":1742326903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977625000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":73,"alternative-id":["S0960977625000104"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2025.103881","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2025.103881","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103881"}}